FTC Solar (FTCI) news
Recent news
First Tracks Biotherapeutics shares rise 13.3% premarket after positive results from celiac disease drug trial
First Tracks Biotherapeutics Inc. (NASDAQ: FTBT) reported a 13.3% increase in premarket trading on October 12, 2026, following the release of positive clinical trial results . The company announced that the drug demonstrated a favorable safety profile and showed measurable efficacy in reducing…
AInvest Wire · 2d agoMarsons - Approves joint venture with Cleanhill Partners in the United States
Marsons, a diversified investment firm, has announced the approval of a joint venture with Cleanhill Partners in the United States, marking a strategic expansion into the energy transition sector. The partnership will focus on investing in companies that are advancing the generation, delivery, and…
AInvest Wire · Oct 6, 2026FTC Solar - Future cash balance covenant adjusted to $15 mln, tested from January 4, 2027
FTC Solar Inc. (FTCI) has announced an adjustment to its cash balance covenant, which will be set at $15 million and tested starting January 4, 2027. This update follows the company’s recent financial performance and ongoing discussions with lenders. As of Q2 2026, the company ended the quarter…
AInvest Wire · Oct 5, 2026Ftc Solar - Full-year 2026 adj EBITDA covenant removed
AInvest Wire · Oct 5, 2026Ftc Solar - $5 mln cash repayment deferred to March 31, 2027
AInvest Wire · Oct 5, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.